Beyond systemic effects, insulin resistance may impair lung function via adipose tissue dysfunction, which promotes pro-inflammatory adipokines like resistin and reduces anti-inflammatory adiponectin (32, 33). Here, ADIPOQ is linked to Insulin resistance.